Ophthalmology

Top Story

Speaker: Venture capital drives innovation in medical retina research

Speaker: Venture capital drives innovation in medical retina research
February 9, 2016

MIAMI — Robust investment by venture capitalists is making up for stagnant government funding for medical research, particularly in the ophthalmic and biotechnology sectors, a speaker told colleagues here.

“Necessity is the mother invention. I like to say that prosperity is the father of innovation. We can’t have innovation unless we have a robust economy because we need that money to drive the innovation,” Emmett T. Cunningham Jr., MD, PhD, MPH, said at Angiogenesis, Exudation, and Degeneration 2016.

Breaking News

Senate proposes new safety requirements for reusable devices

February 9, 2016
The Senate Committee on Health, Education, Labor and Pensions today favorably reported a bill requiring manufacturers of reusable medical devices like duodenoscopes to…
Breaking News

Legislators ask for national surveillance of neurological illnesses

February 9, 2016
The Senate health committee today recommended the establishment of a national surveillance system for neurological diseases.The objective of the “Advancing…
Breaking News

Senate proposes EHR fix for physicians, patients

February 9, 2016
The U.S. Senate Committee on Health, Education, Labor and Pensions unanimously recommended a measure today that would improve the use of electronic health records for…
Breaking News

New bill supports young researchers

February 9, 2016
The Senate health committee recommended a bill today that would improve opportunities for new researchers in the United States. The “Next Generation Researchers…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »
CME

Early to Advanced AMD: Defining the Importance of Prompt Diagnosis and Treatment

This activity is supported by an educational grant from Genentech, Inc.

Management of the geographic atrophy seen in late-stage dry age-related macular degeneration (AMD) poses several…
More »
Featured
Meeting News CoverageVideo

VIDEO: Surgeon anticipates FDA approval of collagen cross-linking for treatment of keratoconus, ectasia

February 2, 2016
More »
morganatic-roan